Simple, direct drug susceptibility testing technique for diagnosis of drug-resistant tuberculosis in resource-poor settings

被引:3
作者
Kim, C-K. [1 ]
Joo, Y-T. [1 ]
Lee, E. P. [1 ]
Park, Y. K. [1 ]
Kim, H-J. [1 ]
Kim, S. J. [1 ]
机构
[1] Korean Inst TB, Korean Natl TB Assoc, Seoul, South Korea
关键词
Kudoh-modified Ogawa medium; MDR-TB; XDR-TB; programmatic management of drug-resistant TB; MYCOBACTERIA; SENSITIVITY;
D O I
10.5588/ijtld.12.1009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: The Korean Institute of Tuberculosis, Seoul, Republic of Korea. OBJECTIVE: To develop a simple, direct drug susceptibility testing (DST) technique using Kudoh-modified Ogawa (KMO) medium. DESIGN: The critical concentrations of isoniazid (INH), rifampicin (RMP), kanamycin (KM) and ofloxacin (OFX) for KMO medium were calibrated by comparing the minimal inhibitory concentrations (MICs) against clinical isolates of Mycobacterium tuberculosis on KMO with those on Lowenstein-Jensen (q). The performance of the direct KMO DST technique was evaluated on 186 smear-positive sputum specimens and compared with indirect LJ DST. RESULTS: Agreement of MICs on direct vs. indirect DST was high for INH, RMP and OFX. KM MICs on KMO were 10 mu g/ml higher than those on LJ. The critical concentrations of INH, RAP, OFX and KM for KMO were therefore set at 0.2, 40.0, 2.0, and 40.0 mu g/ml. The evaluation of direct DST of smear-positive sputum specimens showed 100% agreement with indirect LJ DST for INH and RMP. However, the respective susceptible and resistant predictive values were 98.8% and 100% for OFX, and 100% and 80% for KM. CONCLUSION: Direct DST using KMO is useful, with clear advantages of a shorter turnaround time, procedural simplicity and low cost compared to indirect DST. It may be most indicated in resource-poor settings for programmatic management of drug-resistant tuberculosis.
引用
收藏
页码:1212 / 1216
页数:5
相关论文
共 16 条
  • [11] Rieder HansL., 2007, Priorities for Tuberculosis Bacteriology Services in Low-Income Countries
  • [12] Evaluation of the Xpert MTB/RIF Assay for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting
    Theron, Grant
    Peter, Jonny
    van Zyl-Smit, Richard
    Mishra, Hridesh
    Streicher, Elizabeth
    Murray, Samuel
    Dawson, Rodney
    Whitelaw, Andrew
    Hoelscher, Michael
    Sharma, Surendra
    Pai, Madhukar
    Warren, Robin
    Dheda, Keertan
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (01) : 132 - 140
  • [13] False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications
    Van Rie, A.
    Mellet, K.
    John, M-A.
    Scott, L.
    Page-Shipp, L.
    Dansey, H.
    Victor, T.
    Warren, R.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (02) : 206 - 208
  • [14] World Health Organization, 2011, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and Rifampicin resistance: Xpert MTB/RIF system
  • [15] World Health Organization, 2008, WHOHTMTB2008394
  • [16] World Health Organization (WHO), 2008, UG NAT GUID PROGR MA